Ruvonoflast

Intervention Phase 2

1 paper1 finding

1 lab

Funder: University of Washington

Animals1

Outcomes

1

Obesity

downin mice1

1 study

Ruvonoflast decreases obesity in mice.
“NT-0249 and NT-0796, reverse obesity in the DIO mouse model”
Animalsdiet-induced obesity
Reversal of High Fat Diet-Induced Obesity, Systemic Inflammation, and Astrogliosis by the NLRP3 Inflammasome Inhibitors NT-0249 and NT-0796
The Journal of pharmacology and experimental therapeutics10 Feb 2024

More on Obesity

Development

Companies: RezeraPhase 2obesity, type 2 diabetes

Latest

The Journal of Pharmacology and Experimental Therapeutics10 Feb

Reversal of High Fat Diet-Induced Obesity, Systemic Inflammation, and Astrogliosis by the NLRP3 Inflammasome Inhibitors NT-0249 and NT-0796

Experiments in miceObesity